GUFIC BIOSCIENCES Financial Statement Analysis
|
||
The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -16.89 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹691 Cr | ₹779 Cr | ₹488 Cr | ₹379 Cr | ₹351 Cr |
Expenses | ₹556 Cr | ₹631 Cr | ₹404 Cr | ₹327 Cr | ₹305 Cr |
Operating Profit (Excl OI) | ₹135 Cr | ₹148 Cr | ₹84 Cr | ₹52 Cr | ₹46 Cr |
Other Income | ₹2.57 Cr | ₹3.10 Cr | ₹3.73 Cr | ₹5.79 Cr | ₹4.17 Cr |
Interest | ₹8.22 Cr | ₹5.37 Cr | ₹14 Cr | ₹14 Cr | ₹10 Cr |
Depreciation | ₹22 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr | ₹4.65 Cr |
Profit Before Tax | ₹107 Cr | ₹127 Cr | ₹58 Cr | ₹30 Cr | ₹35 Cr |
Profit After Tax | ₹80 Cr | ₹96 Cr | ₹44 Cr | ₹23 Cr | ₹22 Cr |
Consolidated Net Profit | ₹80 Cr | ₹96 Cr | ₹44 Cr | ₹23 Cr | ₹22 Cr |
Earnings Per Share (Rs) | ₹8.22 | ₹9.89 | ₹4.56 | ₹2.34 | ₹2.82 |
PAT Margin (%) | 9.95 | 11.30 | 8.53 | 5.80 | 6.09 |
ROE(%) | 25.84 | 43.31 | 29.22 | 22.17 | 33.89 |
ROCE(%) | 23.23 | 47.29 | 30.05 | 21.01 | 29.65 |
Total Debt/Equity(x) | 0.90 | 0.23 | 0.32 | 0.90 | 1.30 |
Key Financials |
||
Market Cap | : | ₹ 2,840.0 Cr |
Revenue (TTM) | : | ₹ 784.7 Cr |
Net Profit(TTM) | : | ₹ 84.2 Cr |
EPS (TTM) | : | ₹ 8.4 |
P/E (TTM) | : | 33.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
GUFIC BIOSCIENCES | 0.4% | -7.8% | 52.5% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | -11.36 % |
5 Yr CAGR | 18.46 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹691 Cr | -11.36 | |
Mar2022 | ₹779 Cr | 59.76 | |
Mar2021 | ₹488 Cr | 28.74 | |
Mar2020 | ₹379 Cr | 8.00 | |
Mar2019 | ₹351 Cr | - |
GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | -9.04 % |
5 Yr CAGR | 30.81 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹135 Cr | -9.04 | |
Mar2022 | ₹148 Cr | 76.39 | |
Mar2021 | ₹84 Cr | 61.03 | |
Mar2020 | ₹52 Cr | 13.33 | |
Mar2019 | ₹46 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.63 % |
5 Yr CAGR | 10.44 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 19.5% | 2.63 | |
Mar2022 | 19% | 10.40 | |
Mar2021 | 17.21% | 25.07 | |
Mar2020 | 13.76% | 4.96 | |
Mar2019 | 13.11% | - |
GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | -16.84 % |
5 Yr CAGR | 38.06 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹80 Cr | -16.84 | |
Mar2022 | ₹96 Cr | 116.68 | |
Mar2021 | ₹44 Cr | 94.96 | |
Mar2020 | ₹23 Cr | 3.40 | |
Mar2019 | ₹22 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -11.95 % |
5 Yr CAGR | 13.06 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 9.95 % | -11.95 | |
Mar2022 | 11.3 % | 32.47 | |
Mar2021 | 8.53 % | 47.07 | |
Mar2020 | 5.8 % | -4.76 | |
Mar2019 | 6.09 % | - |
GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | -16.89 % |
5 Yr CAGR | 30.66 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹8.22 | -16.89 | |
Mar2022 | ₹9.89 | 116.89 | |
Mar2021 | ₹4.56 | 94.87 | |
Mar2020 | ₹2.34 | -17.02 | |
Mar2019 | ₹2.82 | - |
GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | -50.88 % |
5 Yr CAGR | -5.92 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 23.23% | -50.88 | |
Mar2022 | 47.29% | 57.37 | |
Mar2021 | 30.05% | 43.03 | |
Mar2020 | 21.01% | -29.14 | |
Mar2019 | 29.65% | - |
GUFIC BIOSCIENCES Share Price vs Sensex
Current Share Price | : | ₹283.2 |
Current MarketCap | : | ₹ 2,840.0 Cr |
Updated EOD on | : | Mar 28,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | 0.4% |
-7.8% |
52.5% |
SENSEX | -0.4% |
-0.9% |
25.8% |
GUFIC BIOSCIENCES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDSMALLCAP | 1.9% | -4.4% | 61.2% |
S&P BSE SMALL CAP | 1.8% | -6.7% | 58.8% |
S&P BSE HEALTHCARE | 1% | -3.2% | 60.6% |
S&P BSE ALLCAP | 0.8% | -1.8% | 40.5% |
You may also like the below Video Courses
FAQ about GUFIC BIOSCIENCES Financials
How the annual revenues of GUFIC BIOSCIENCES have changed ?
The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .
How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -16.89 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs